Mark T. Liddament

1.4k total citations · 1 hit paper
6 papers, 1.1k citations indexed

About

Mark T. Liddament is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Mark T. Liddament has authored 6 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Virology and 2 papers in Infectious Diseases. Recurrent topics in Mark T. Liddament's work include HIV Research and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). Mark T. Liddament is often cited by papers focused on HIV Research and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). Mark T. Liddament collaborates with scholars based in United States, Australia and New Zealand. Mark T. Liddament's co-authors include Reuben S. Harris, April J. Schumacher, William L. Brown, Guylaine Haché, Jasna Rakonjac, Vickery L. Arcus, Anthony Doyle, David Laine, Jean Husten and Laurie Pukac and has published in prestigious journals such as Journal of Biological Chemistry, Nature reviews. Immunology and PLoS ONE.

In The Last Decade

Mark T. Liddament

6 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retroviral restriction by APOBEC proteins

2004 507 citations Reuben S. Harris, Mark T. Liddament Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark T. Liddament United States	6	711	435	401	385	298	6	1.1k
Phuong Thi Nguyen Sarkis United States	14	619 0.9×	342 0.8×	302 0.8×	315 0.8×	430 1.4×	16	984
Kristine M. Rose United States	12	834 1.2×	405 0.9×	626 1.6×	418 1.1×	491 1.6×	12	1.3k
Krista A. Delviks‐Frankenberry United States	19	748 1.1×	471 1.1×	582 1.5×	228 0.6×	236 0.8×	31	1.2k
Elena Sokolskaja United States	11	957 1.3×	759 1.7×	359 0.9×	364 0.9×	578 1.9×	11	1.4k
Henning Hofmann Germany	14	782 1.1×	525 1.2×	306 0.8×	402 1.0×	564 1.9×	19	1.3k
April J. Schumacher United States	8	474 0.7×	339 0.8×	273 0.7×	387 1.0×	195 0.7×	10	827
Eric C. Logue United States	10	658 0.9×	406 0.9×	279 0.7×	286 0.7×	497 1.7×	10	1.1k
Diana Ayinde France	11	989 1.4×	392 0.9×	395 1.0×	371 1.0×	690 2.3×	11	1.3k
John S. Albin United States	12	594 0.8×	333 0.8×	364 0.9×	252 0.7×	237 0.8×	21	830
Dominik Hotter Germany	19	566 0.8×	355 0.8×	258 0.6×	283 0.7×	568 1.9×	25	1.1k

Countries citing papers authored by Mark T. Liddament

Since Specialization

Citations

This map shows the geographic impact of Mark T. Liddament's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Liddament with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Liddament more than expected).

Fields of papers citing papers by Mark T. Liddament

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Liddament. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Liddament. The network helps show where Mark T. Liddament may publish in the future.

Co-authorship network of co-authors of Mark T. Liddament

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Liddament. A scholar is included among the top collaborators of Mark T. Liddament based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Liddament. Mark T. Liddament is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zacchi, Lucía F., Rodrigo A. V. Morales, Alexander Karnowski, et al.. (2022). Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies. International Journal of Molecular Sciences. 23(15). 8470–8470. 13 indexed citations

2.

Liddament, Mark T., et al.. (2019). Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab. Allergy Asthma and Immunology Research. 11(2). 291–291. 14 indexed citations

3.

Rakonjac, Jasna, et al.. (2014). Tracking Molecular Recognition at the Atomic Level with a New Protein Scaffold Based on the OB-Fold. PLoS ONE. 9(1). e86050–e86050. 15 indexed citations

4.

Haché, Guylaine, Mark T. Liddament, & Reuben S. Harris. (2005). The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain. Journal of Biological Chemistry. 280(12). 10920–10924. 162 indexed citations

5.

Liddament, Mark T., William L. Brown, April J. Schumacher, & Reuben S. Harris. (2004). APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo. Current Biology. 14(15). 1385–1391. 374 indexed citations

6.

Harris, Reuben S. & Mark T. Liddament. (2004). Retroviral restriction by APOBEC proteins. Nature reviews. Immunology. 4(11). 868–877. 507 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact